$151.25
4.27%
NYSE, Nov 21, 10:08 pm CET
Why the stock moved Why the stock moved Beta

Agilent Technologies Stock price

$151.25
+5.57 3.82% 1M
+42.34 38.88% 6M
+16.91 12.59% YTD
+19.19 14.53% 1Y
+6.11 4.21% 3Y
+39.04 34.79% 5Y
+111.22 277.84% 10Y
+126.24 504.67% 20Y
NYSE, Closing price Fri, Nov 21 2025
+6.19 4.27%

New AI Insights on Agilent Technologies Insights AI Insights on Agilent Technologies

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$42.9b
Enterprise Value
$44.8b
Net debt
$1.9b
Cash
$1.5b
Shares outstanding
283.6m
Valuation (TTM | estimate)
P/E
35.4 | 26.6
P/S
6.3 | 6.1
EV/Sales
6.6 | 6.3
EV/FCF
41.1
P/B
6.7
Dividends
DPS
$0.99
Yield 1Y | 5Y
0.7% | 0.7%
Growth 1Y | 5Y
5.1% | 6.6%
Payout 1Y | 3Y
21.3% | 21.0%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$6.8b | $7.1b
EBITDA
$1.8b | $2.0b
EBIT
$1.5b | $1.8b
Net Income
$1.2b | $1.6b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
4.5% | 8.4%
EBITDA
-2.5% | 12.3%
EBIT
-5.1% | 12.5%
Net Income
-13.7% | 25.1%
Free Cash Flow
-23.2%
Margin (TTM | estimate)
Gross
52.9%
EBITDA
26.7% | 29.0%
EBIT
22.4%
Net
18.0% | 22.9%
Free Cash Flow
16.0%
Financial Health
Equity Ratio
49.8%
Return on Equity
21.9%
ROCE
14.7%
ROIC
14.0%
Debt/Equity
0.5
More
EPS
$4.3
FCF per Share
$3.8
Short interest
1.4%
Employees
18k
Rev per Employee
$360.0k
Show more

Is Agilent Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,052 stocks worldwide.

Agilent Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Agilent Technologies forecast:

16x Buy
59%
11x Hold
41%

Analyst Opinions

27 Analysts have issued a Agilent Technologies forecast:

Buy
59%
Hold
41%

Financial data from Agilent Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
6,788 6,788
4% 4%
100%
- Direct Costs 3,196 3,196
9% 9%
47%
3,592 3,592
1% 1%
53%
- Selling and Administrative Expenses 1,626 1,626
9% 9%
24%
- Research and Development Expense 443 443
3% 3%
7%
1,809 1,809
2% 2%
27%
- Depreciation and Amortization 286 286
14% 14%
4%
EBIT (Operating Income) EBIT 1,523 1,523
5% 5%
22%
Net Profit 1,220 1,220
14% 14%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Agilent Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilent Technologies Stock News

Neutral
Seeking Alpha
one day ago
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Neutral
Business Wire
5 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on Jan. 28, 2026, to all shareholders of record as of the close of business on Jan. 6, 2026. The timing and amounts of future dividends are subject to the determination and approval by Agilent's board of direc...
Neutral
Business Wire
6 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Enterprise Transformation Officer Tom Callihan and Head of Investor Relations Tejas Savant will participate in a fireside chat at Citi's 2025 Global Healthcare Conference. The event is scheduled for 9 to 9:45 a.m. EDT on Thursday, Dec. 4, 2025, in Miami, Florida. A live audio webcast and replay ...
More Agilent Technologies News

Company Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Head office United States
CEO Padraig Mcdonnell
Employees 17,900
Founded 1999
Website www.agilent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today